Moderna’s Melanoma Vaccine Breakthrough | Texas News

Texas News Today | 2 Min News | The Daily News Now! · Aug 20, 2026 · 1m

Moderna’s stock soared as its experimental mRNA melanoma vaccine, teamed with Merck’s immunotherapy, showed stunning results—dramatically reducing cancer recurrence in high-risk patients. This personalized treatment, designed to target a patient’s unique tumor, could redefine post-surgery care for melanoma, offering real hope for long-term remission and potentially shifting the entire approach to cancer therapy. Experts hail it as a landmark moment in oncology, signaling a future where tailored vaccines become standard—and Moderna’s next big leap may just be here. Listen in comfort:Get a…